RESEARCHER PROFILE
Mehtap Aydın
← Back to Ümraniye Eğitim ve Araştırma Hastanesi
M
Ümraniye Eğitim ve Araştırma Hastanesi
Mehtap Aydın works in COVID-19 Clinical Research Studies, Antibiotic Use and Resistance, SARS-CoV-2 and COVID-19 Research, Antibiotic Resistance in Bacteria, Nosocomial Infections in ICU. Recorded institutional associations include Ümraniye Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi.
99Publications
2,056Citations
20H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
2021 · 896 citationsUpdate on treatment options for spinal brucellosis
2013 · 133 citationsCombined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
2021 · 88 citationsRational use of medicine in dentistry: do dentists prescribe antibiotics in appropriate indications?
2017 · 76 citationsHealthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality
2016 · 62 citationsCytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis
2008 · 54 citationsRapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections
2017 · 53 citationsFactors affecting responsiveness to hepatitis B immunization in dialysis patients
2017 · 50 citationsResveratrol Protects Sepsis-Induced Oxidative DNA Damage in Liver and Kidney of Rats
2016 · 46 citationsSeroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey
2021 · 46 citationsCharacteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting
2022 · 44 citationsChanges in antimicrobial resistance and outcomes of health care–associated infections
2021 · 35 citationsPredictors of fatality in influenza A virus subtype infections among inpatients in the 2015–2016 season
2019 · 33 citationsEffect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group
2020 · 32 citationsA review of uncommon cytopathologic diagnoses of pleural effusions from a chest diseases center in Turkey
2011 · 30 citationsEpidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007‐2014
2017 · 28 citationsAflatoxin levels in chronic hepatitis B patients with cirrhosis or hepatocellular carcinoma in B alıkesir, T urkey
2015 · 25 citationsClinicopathologic Features and Prognostic Significance of Lung Tumours with Mixed Histologic Patterns
2009 · 20 citationsThe effect of moderate and severe COVID-19 pneumonia on short-term right ventricular functions: a prospective observational single pandemic center analysis
2021 · 20 citationsAnalysis of laboratory parameters in patients with COVID-19: Experiences from a pandemic hospital
2021 · 20 citationsEffects of COVID-19 Disease on DNA Damage, Oxidative Stress and Immune Responses
2023 · 18 citationsThe Turkish Clinical Microbiology and Infectious Diseases Society (KLİMİK) Evidence-Based Guideline for the Diagnosis and Treatment of Brucellosis, 2023
2023 · 17 citationsThe expression of GST isoenzymes and p53 in non-small cell lung cancer.
2010 · 16 citationsRelative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study
2019 · 16 citationsSafety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial
2022 · 15 citations
